Translating Duke Health News

Unlocking the Secrets of Neurodegenerative Diseases

Translating Duke Health (TDH) initiative is taking a deep look both into the human brain and across the human lifespan. Basic and translational research scientists across Duke are working to unravel the secrets of the human brain to discover new therapies and harness the brain’s own capacity for resilience and self-repair.  

White Glove Service for Brain and Spine Metastasis Patients

The Duke Center for Brain and Spine Metastasis (DCBSM) has become one of the most comprehensive destination programs in the country for treating the growing population of patients whose cancer has spread to the brain, spine, and other parts of the central nervous system. 

Immune System Can be Coaxed into Selecting Key Antibodies to Fight HIV

Animal study shows ability to overcome a long-standing hurdle in HIV vaccine development

Researchers have cleared a major obstacle in the development of an HIV vaccine, proving in animal models that effective, yet short-lasting antibodies can be coaxed into multiplying as a fighting force against the virus.

The finding, led by a team of researchers at the Duke Human Vaccine Institute (DHVI) and Boston Children’s Hospital, publishes online Dec. 5.

Translating Duke Health Initiative Celebrates Two Years of Success

The Translating Duke Health Initiative (TDH) —a multi-year, multidisciplinary program designed to bring Duke teams together to address society’s most challenging health issues—continues to push forward with innovative projects and new partnerships since its launch in Fall 2017. 

The goal of the initiative is to further develop expertise in five key areas—brain cancer, brain resilience, cardiovascular health, immunology, and children’s health—by focusing on faculty recruitment, retention, grant funding, research infrastructure, and educational opportunities.

Gable awarded grant to study origins, possible treatments for CIDP

Duke Neurologist, Karissa Gable, MD, is investigating the pathophysiologic mechanisms of chronic inflammatory demyelinating polyneuropathy (CIDP), advancing our understanding of this autoimmune disease and opening new potential roles for treatment. This research is made possible thanks to the GBS|CIDP Foundation International, which awarded Gable a one-year research grant.